Effects of leukotriene C4 on the cerebral microvasculature

W. G. Mayhan, G. Sahagun, R. Spector, D. D. Heistad

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Leukotriene C4, which is synthesized during cerebral ischemia, may contribute to disruption of the blood-brain barrier. The purpose of this study was to determine whether leukotriene C4 constricts cerebral arterioles and disrupts the blood-brain barrier. We used intravital fluorescent microscopy in hamsters and compared responses of vessels in the cerebrum with vessels in the cheek pouch. Increases in permeability of the cheek pouch and disruption of the blood-brain barrier were quantitated after superfusion with leukotriene C4 (0.3, 3.0, and 30 nM) by the formation of microvascular leaky sites. Changes in diameter of arterioles in the cheek pouch and cerebrum also were examined. In the cheek pouch, leukotriene C4 produced a dose related decrease in diameter of arterioles (maximum = 40 ± 8%; mean ± SE) and an increase in microvascular permeability (maximum = 16 ± 2 leaky sites). In contrast, in the cerebrum, leukotriene C4 produced only modest constriction of arterioles (maximum = 12 ± 5%) and minimal disruption of the blood-brain barrier (maximum = 2 ± 1 leaky sites). Thus the findings indicate that leukotriene C4, in contrast to its potent vasoconstrictor effects and increase in permeability in the hamster cheek pouch, produces only modest cerebral vasoconstriction and minimal disruption of the blood-brain barrier.

Original languageEnglish (US)
Pages (from-to)H471-H474
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume251
Issue number2 (20/2)
StatePublished - Jan 1 1986

Fingerprint

Leukotriene C4
Microvessels
Cheek
Blood-Brain Barrier
Arterioles
Cerebrum
Cricetinae
Permeability
Capillary Permeability
Vasoconstrictor Agents
Vasoconstriction
Brain Ischemia
Constriction

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Effects of leukotriene C4 on the cerebral microvasculature. / Mayhan, W. G.; Sahagun, G.; Spector, R.; Heistad, D. D.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 251, No. 2 (20/2), 01.01.1986, p. H471-H474.

Research output: Contribution to journalArticle

Mayhan, WG, Sahagun, G, Spector, R & Heistad, DD 1986, 'Effects of leukotriene C4 on the cerebral microvasculature', American Journal of Physiology - Heart and Circulatory Physiology, vol. 251, no. 2 (20/2), pp. H471-H474.
Mayhan, W. G. ; Sahagun, G. ; Spector, R. ; Heistad, D. D. / Effects of leukotriene C4 on the cerebral microvasculature. In: American Journal of Physiology - Heart and Circulatory Physiology. 1986 ; Vol. 251, No. 2 (20/2). pp. H471-H474.
@article{2d3eda89a8cc47e9babcab1020db49b5,
title = "Effects of leukotriene C4 on the cerebral microvasculature",
abstract = "Leukotriene C4, which is synthesized during cerebral ischemia, may contribute to disruption of the blood-brain barrier. The purpose of this study was to determine whether leukotriene C4 constricts cerebral arterioles and disrupts the blood-brain barrier. We used intravital fluorescent microscopy in hamsters and compared responses of vessels in the cerebrum with vessels in the cheek pouch. Increases in permeability of the cheek pouch and disruption of the blood-brain barrier were quantitated after superfusion with leukotriene C4 (0.3, 3.0, and 30 nM) by the formation of microvascular leaky sites. Changes in diameter of arterioles in the cheek pouch and cerebrum also were examined. In the cheek pouch, leukotriene C4 produced a dose related decrease in diameter of arterioles (maximum = 40 ± 8{\%}; mean ± SE) and an increase in microvascular permeability (maximum = 16 ± 2 leaky sites). In contrast, in the cerebrum, leukotriene C4 produced only modest constriction of arterioles (maximum = 12 ± 5{\%}) and minimal disruption of the blood-brain barrier (maximum = 2 ± 1 leaky sites). Thus the findings indicate that leukotriene C4, in contrast to its potent vasoconstrictor effects and increase in permeability in the hamster cheek pouch, produces only modest cerebral vasoconstriction and minimal disruption of the blood-brain barrier.",
author = "Mayhan, {W. G.} and G. Sahagun and R. Spector and Heistad, {D. D.}",
year = "1986",
month = "1",
day = "1",
language = "English (US)",
volume = "251",
pages = "H471--H474",
journal = "American Journal of Physiology - Renal Physiology",
issn = "0363-6127",
publisher = "American Physiological Society",
number = "2 (20/2)",

}

TY - JOUR

T1 - Effects of leukotriene C4 on the cerebral microvasculature

AU - Mayhan, W. G.

AU - Sahagun, G.

AU - Spector, R.

AU - Heistad, D. D.

PY - 1986/1/1

Y1 - 1986/1/1

N2 - Leukotriene C4, which is synthesized during cerebral ischemia, may contribute to disruption of the blood-brain barrier. The purpose of this study was to determine whether leukotriene C4 constricts cerebral arterioles and disrupts the blood-brain barrier. We used intravital fluorescent microscopy in hamsters and compared responses of vessels in the cerebrum with vessels in the cheek pouch. Increases in permeability of the cheek pouch and disruption of the blood-brain barrier were quantitated after superfusion with leukotriene C4 (0.3, 3.0, and 30 nM) by the formation of microvascular leaky sites. Changes in diameter of arterioles in the cheek pouch and cerebrum also were examined. In the cheek pouch, leukotriene C4 produced a dose related decrease in diameter of arterioles (maximum = 40 ± 8%; mean ± SE) and an increase in microvascular permeability (maximum = 16 ± 2 leaky sites). In contrast, in the cerebrum, leukotriene C4 produced only modest constriction of arterioles (maximum = 12 ± 5%) and minimal disruption of the blood-brain barrier (maximum = 2 ± 1 leaky sites). Thus the findings indicate that leukotriene C4, in contrast to its potent vasoconstrictor effects and increase in permeability in the hamster cheek pouch, produces only modest cerebral vasoconstriction and minimal disruption of the blood-brain barrier.

AB - Leukotriene C4, which is synthesized during cerebral ischemia, may contribute to disruption of the blood-brain barrier. The purpose of this study was to determine whether leukotriene C4 constricts cerebral arterioles and disrupts the blood-brain barrier. We used intravital fluorescent microscopy in hamsters and compared responses of vessels in the cerebrum with vessels in the cheek pouch. Increases in permeability of the cheek pouch and disruption of the blood-brain barrier were quantitated after superfusion with leukotriene C4 (0.3, 3.0, and 30 nM) by the formation of microvascular leaky sites. Changes in diameter of arterioles in the cheek pouch and cerebrum also were examined. In the cheek pouch, leukotriene C4 produced a dose related decrease in diameter of arterioles (maximum = 40 ± 8%; mean ± SE) and an increase in microvascular permeability (maximum = 16 ± 2 leaky sites). In contrast, in the cerebrum, leukotriene C4 produced only modest constriction of arterioles (maximum = 12 ± 5%) and minimal disruption of the blood-brain barrier (maximum = 2 ± 1 leaky sites). Thus the findings indicate that leukotriene C4, in contrast to its potent vasoconstrictor effects and increase in permeability in the hamster cheek pouch, produces only modest cerebral vasoconstriction and minimal disruption of the blood-brain barrier.

UR - http://www.scopus.com/inward/record.url?scp=0040373358&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0040373358&partnerID=8YFLogxK

M3 - Article

C2 - 3740300

AN - SCOPUS:0040373358

VL - 251

SP - H471-H474

JO - American Journal of Physiology - Renal Physiology

JF - American Journal of Physiology - Renal Physiology

SN - 0363-6127

IS - 2 (20/2)

ER -